Rick Doblin

really leave either, then you can process it. So this study that will be done here in Texas with active duty soldiers, again, is going to be a combination of MDMA with prolonged exposure. The Walter Reed study is combining MDMA with what they call acceptance and commitment therapy, different kind of approaches.

Well,

Well,

Well,

Yeah, yeah. And I think that MAPS has started funding studies combining MDMA with cognitive processing therapy as well. But the one that I think is the most, potentially the most valuable is called cognitive behavioral conjoined therapy. Conjoint means couples or diets. And so what happens is the designated patient, the veteran with PTSD, is where the attention is focused.

Yeah, yeah. And I think that MAPS has started funding studies combining MDMA with cognitive processing therapy as well. But the one that I think is the most, potentially the most valuable is called cognitive behavioral conjoined therapy. Conjoint means couples or diets. And so what happens is the designated patient, the veteran with PTSD, is where the attention is focused.

Yeah, yeah. And I think that MAPS has started funding studies combining MDMA with cognitive processing therapy as well. But the one that I think is the most, potentially the most valuable is called cognitive behavioral conjoined therapy. Conjoint means couples or diets. And so what happens is the designated patient, the veteran with PTSD, is where the attention is focused.

But when they have PTSD, it affects their families. It affects their partners. And so cognitive behavioral conjoined therapy was developed by this woman, Candice Monson, at the Boston VA University. And that's where they bring in the partner as well as the veteran, and they both get therapy.

But when they have PTSD, it affects their families. It affects their partners. And so cognitive behavioral conjoined therapy was developed by this woman, Candice Monson, at the Boston VA University. And that's where they bring in the partner as well as the veteran, and they both get therapy.

But when they have PTSD, it affects their families. It affects their partners. And so cognitive behavioral conjoined therapy was developed by this woman, Candice Monson, at the Boston VA University. And that's where they bring in the partner as well as the veteran, and they both get therapy.

And so back in 2014, when finally I was working with Richard Rockefeller and his cousin, Senator Jay Rockefeller, who was on the Senate Veterans Affairs Committee, and they finally convinced the FDA, I mean the VA, to be willing to let MAPS support research with MDMA. They said that they would not let it – they wouldn't refer veterans. They couldn't do it inside the VA. We had to pay for it.

And so back in 2014, when finally I was working with Richard Rockefeller and his cousin, Senator Jay Rockefeller, who was on the Senate Veterans Affairs Committee, and they finally convinced the FDA, I mean the VA, to be willing to let MAPS support research with MDMA. They said that they would not let it – they wouldn't refer veterans. They couldn't do it inside the VA. We had to pay for it.

And so back in 2014, when finally I was working with Richard Rockefeller and his cousin, Senator Jay Rockefeller, who was on the Senate Veterans Affairs Committee, and they finally convinced the FDA, I mean the VA, to be willing to let MAPS support research with MDMA. They said that they would not let it – they wouldn't refer veterans. They couldn't do it inside the VA. We had to pay for it.

But that the first thing they wanted us to do was combine MDMA with cognitive behavioral conjoined therapy where both people now get MDMA. And the results were better than anything they've ever got before in studying this therapy, both in reduction of PTSD but also in strength of the relationship.

But that the first thing they wanted us to do was combine MDMA with cognitive behavioral conjoined therapy where both people now get MDMA. And the results were better than anything they've ever got before in studying this therapy, both in reduction of PTSD but also in strength of the relationship.

But that the first thing they wanted us to do was combine MDMA with cognitive behavioral conjoined therapy where both people now get MDMA. And the results were better than anything they've ever got before in studying this therapy, both in reduction of PTSD but also in strength of the relationship.

The answer is no. People do use 5-HTP and it can be helpful. Can you explain what that does? Yeah. So 5-HTP is your precursor for serotonin. So when we started research with the FDA, this was now 1992, the very first time that they permitted MDMA research was 1992. And as I said, MDMA had been used as a therapy drug since the middle 70s through the 80s, criminalized in 85.

The answer is no. People do use 5-HTP and it can be helpful. Can you explain what that does? Yeah. So 5-HTP is your precursor for serotonin. So when we started research with the FDA, this was now 1992, the very first time that they permitted MDMA research was 1992. And as I said, MDMA had been used as a therapy drug since the middle 70s through the 80s, criminalized in 85.

The answer is no. People do use 5-HTP and it can be helpful. Can you explain what that does? Yeah. So 5-HTP is your precursor for serotonin. So when we started research with the FDA, this was now 1992, the very first time that they permitted MDMA research was 1992. And as I said, MDMA had been used as a therapy drug since the middle 70s through the 80s, criminalized in 85.

And people have felt that sometimes, and I think it's very much the case, that you're tired after MDMA, that people talk about a serotonin depletion. And so when you take 5-HTP, that can be helpful. But when we started with the FDA, they said, all this information that you've got from before from underground use or from before when it was still legal doesn't matter to us.